Please assess the completion status of the following clinical trial:

Trial Title: Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. A pathologically (histological or cytological) confirmed clinical diagnosis of non-small cell lung cancer (NSCLC) or GI cancer~2. Stage 3 or 4 disease and eligible for anti-cancer treatment~3. Performance status (PS) of 0 - 2 as determined by the Eastern Cooperative Oncology Group-Performance Status~4. Life expectancy estimated at \> 4 months~5. Age 18 years or older~6. Willing and able to provide informed consent~7. Must be approved for participation by the oncology treatment team~8. Able to communicate in French or English~Exclusion Criteria:~1. Contraindication to exercise as determined by the oncology treatment team~2. Severe cardiac or neuro-muscular/skeletal disease~3. Engaging in interventions to address anxiety or depressive symptoms~4. Brain metastases~5. Active psychiatric conditions~6. Pregnant or breast-feeding mothers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard Exercise (Type: ACTIVE_COMPARATOR): See methods below - standard strength and endurance training
- Qigong exercise (Type: EXPERIMENTAL): See methods below - medical QiGong therapy session

Based on this trial design, predict the completion outcome and termination type (if applicable).